Thus, such small animal models can provide a practical platform and an affordable means for evaluating the efficacy of current MERS-CoV vaccines. Accordingly,transgenic DPP4 mouse models that integrate human DPP4 genes into the mouse genome are being established in several laboratories and are expected to be tested for vaccineefficacy in the near future.